For IPO Boutique's "scale of 1 to 5" BUY rating on Egalet, and our comprehensive analysis, click "Buy Market Research".
Egalet Quote & Chart - Click for current quote - EGLT
About Egalet (adapted from Egalet prospectus): They are a specialty pharmaceutical company developing and planning to commercialize proprietary, abuse-deterrent oral products for the treatment of pain and in other indications.
This description is adapted from prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.
IPO Boutique aggregates information on public companies and private companies, such as "EGLT" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.
Used our Comprehensive Single Promo Advisory and want more?
